GNPX - Genprex, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Genprex, Inc.

3300 Bee Cave Road
Suite 650-227
Austin, TX 78746
United States
(877) 774-4679

Full Time Employees28

Key Executives

NameTitlePayExercisedYear Born
Mr. John Rodney VarnerCo-Founder, Chairman, Pres & CEO886.97kN/A1957
Mr. Ryan M. Confer M.S.Chief Financial Officer606.57kN/A1982
Ms. Catherine M. Vaczy Esq.Exec. VP, Gen. Counsel, Corp. Sec. & Chief Strategy Officer704.93kN/A1961
Dr. Hemant Kumar C.P.M., EMBA, Ph.D.Chief Manufacturing & Technology OfficerN/AN/A1963
Mr. David M. SchlossSr. VP of HRN/AN/AN/A
Mr. Thomas C. Gallagher Esq.Sr. VP of Intellectual Property & LicensingN/AN/AN/A
Dr. William E. Gannon Jr.Member of Clinical Advisory Board & VP of Regulatory AffairsN/AN/AN/A
Dr. Mark S. Berger M.D.Chief Medical OfficerN/AN/A1955
Dr. Jack A. Roth F.A.C.S., FACS, M.D.Chairman of Scientific & Medical Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Corporate Governance

Genprex, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.